title: [Sleep-related cardiac insufficiency and respiratory disorders. Prevalence, physiopathology, and treatment].
abstract: Cheyne-Stokes respiration occurs during sleep in 40-45% of patients with NYHA class III and IV heart failure. Such patients experience repeated episodes of progressively diminishing ventilation associated with desaturation followed by periods of increasing-amplitude ventilation. The mechanism appears to be related to hyperventilation leading to hypocapnia which occurs near a critical threshold of apnea during sleep stages I and stage II and interrupts central ventilatory control. The total duration of the periodic respiration cycle would depend on the increased circulation time subsequent to lowered cardiac output. Brief periods of waking provoked by Cheyne-Stokes respiration, accentuating sympathetic nervous system activity, are an unfavorable prognostic factor in heart failure. Activation of the sympathetic system may be corrected by CPAP although the long-term effect on heart failure remains controversial. Other treatments, such as oxygen therapy or theophylline, combined with optimized treatment of heart failure, have been proposed.
authors.affiliation: Laboratoire d'Explorations Fonctionnelles, Hôpital Antoine-Béclère, Clamart.
authors.forename: P
authors.initials: P
authors.lastname: Escourrou
authors.forename: D
authors.initials: D
authors.lastname: Pellerin
authors.forename: H
authors.initials: H
authors.lastname: Nedelcoux
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002302:Cardiac Output; D002639:Cheyne-Stokes Respiration / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D002648:Child; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D010100:Oxygen / Q000627:therapeutic use; D015995:Prevalence; D012891:Sleep Apnea Syndromes / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy
chemical_list: D010100:Oxygen